ClinConnect ClinConnect Logo
Search / Trial NCT06327334

Brain Heart InterActioNs in Cardiac Arrest. Ancillary Study of the HEAVENwARd Trial

Launched by CMC AMBROISE PARÉ · Mar 22, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Brain Heart Interactions Resuscitated Cardiac Arrest

ClinConnect Summary

This clinical trial, called the "Brain Heart InterActioNs in Cardiac Arrest" study, is part of a larger research project aimed at understanding how the heart and brain interact after a patient has experienced a cardiac arrest. The study focuses on patients who are in a coma after being resuscitated from cardiac arrest, with the goal of finding new ways to predict their recovery. Researchers believe that by examining the connections between brain and heart activity, they can better understand the effects of brain injury caused by lack of oxygen and potentially identify new signs that indicate how well a patient might recover.

To participate in this study, individuals must be admitted to an intensive care unit after a cardiac arrest and be in a coma, meaning they have a low level of consciousness. They should have undergone specific tests that measure brain and heart activity as part of their routine care. However, patients who are not expected to survive or who have certain medical conditions may not be eligible. Participants will have their brain and heart activity monitored to help researchers learn more about how these two organs work together during recovery. This study is currently recruiting and aims to gather valuable information that could improve care for future patients who experience similar situations.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Admitted in intensive care unit (ICU) after resuscitation from cardiac arrest (in-hospital or out-of-hospital)
  • Coma (Glasgow score \< 8) after ROSC, requiring sedation and targeted temperature management for at least 24h
  • EEG with ECG lead performed in routine care
  • Exclusion Criteria:
  • Dying patient (Limitation of life support techniques at admission to the ICU)
  • Limitation of life sustaining treatment before EEG
  • Non-Sinus Rhythm
  • Pregnant or breastfeeding women
  • Patient under protection of the adults (guardianship, curators or safeguard of justice)
  • Opposition by the trusted person or by the patient

About Cmc Ambroise Paré

CMC Ambroise Paré is a distinguished clinical trial sponsor dedicated to advancing medical research and innovation. With a focus on enhancing patient care, the organization specializes in the development and management of clinical trials across various therapeutic areas. CMC Ambroise Paré is committed to rigorous scientific standards, ensuring compliance with regulatory requirements while fostering collaboration among healthcare professionals, researchers, and stakeholders. By leveraging cutting-edge methodologies and a patient-centric approach, the organization aims to contribute to the development of safe and effective treatments, ultimately improving health outcomes and quality of life.

Locations

Nantes, Pays De La Loire, France

Brest, Bretagne, France

Neuilly Sur Seine, Ile De France, France

Marseille, Provence Alpes Côte D'azur, France

Paris, Ile De France, France

Marseille, Provence Alpes Cote D Azur, France

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported